News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Icon Genetics And Novoplant GmbH Announce Broad License Agreement


10/19/2005 5:10:45 PM

Icon Genetics AG, Munich, and Novoplant GmbH, Gatersleben, announced in Ocotber that the two companies entered into a broad licensing agreement that gives Novoplant an access to Icon's proprietary technology platforms, Transgene Operating Systems®, for manufacturing immune response proteins in green plants. The agreement provides Novoplant with a strategically needed freedom to operate in its core business area, animal health. The financial terms of the agreement are not disclosed.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES